Lista de obras - Julie M. Fox - Dominio Público Uruguay

A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

artículo científico publicado en 2020

A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2

artículo científico publicado en 2020

A cross-reactive antibody protects against Ross River virus musculoskeletal disease despite rapid neutralization escape in mice

scientific article published on 06 August 2020

A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection

scientific article published on 01 May 2019

An Evolutionary Insertion in the Mxra8 Receptor-Binding Site Confers Resistance to Alphavirus Infection and Pathogenesis

artículo científico publicado en 2020

Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement

artículo científico publicado en 2018

Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress

artículo científico publicado en 2015

Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis

artículo científico publicado en 2015

Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes

artículo científico publicado en 2014

Drug analog inhibition of indoleamine 2,3-dioxygenase (IDO) activity modifies pattern recognition receptor expression and proinflammatory cytokine responses early during influenza virus infection.

artículo científico publicado en 2014

Human monoclonal antibodies against Ross River virus target epitopes within the E2 protein and protect against disease

scientific article published on 04 May 2020

Immune-Mediated Protection and Pathogenesis of Chikungunya Virus

artículo científico publicado en 2016

Indoleamine 2,3-dioxygenase (IDO) activity during the primary immune response to influenza infection modifies the memory T cell response to influenza challenge

artículo científico publicado en 2014

Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection

scientific article published on 11 April 2013

Interferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells After Influenza Virus Infection

artículo científico publicado en 2015

Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus

artículo científico publicado en 2015

Isospora troglodytes n. sp. (Apicomplexa: Eimeriidae), a new coccidian species from wrens of Costa Rica.

artículo científico publicado en 2011

MUTATIONS IN THE E2 GLYCOPROTEIN AND THE 3' UNTRANSLATED REGION ENHANCE CHIKUNGUNYA VIRUS VIRULENCE IN MICE.

artículo científico publicado en 2017

Modified mRNA Vaccines Protect against Zika Virus Infection

artículo científico publicado en 2017

Modified mRNA Vaccines Protect against Zika Virus Infection

artículo científico publicado en 2017

Mxra8 is a receptor for multiple arthritogenic alphaviruses

artículo científico publicado en 2018

Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis

artículo científico publicado en 2015

Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice

artículo científico publicado en 2016

Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes

scientific article published on 01 February 2019

Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence

artículo científico publicado en 2016

Potently neutralizing and protective human antibodies against SARS-CoV-2

artículo científico publicado en 2020

Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals

artículo científico publicado en 2020

Publisher Correction: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function

scientific article published on 02 September 2020

SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function

artículo científico publicado en 2020

Structural basis of Chikungunya virus inhibition by monoclonal antibodies

artículo científico publicado en 2020

Subsisting H1N1 influenza memory responses are insufficient to protect from pandemic H1N1 influenza challenge in C57BL/6 mice

artículo científico publicado en 2013

Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques

artículo científico publicado en 2017

Lista de obras de Julie M. Fox

A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2

A cross-reactive antibody protects against Ross River virus musculoskeletal disease despite rapid neutralization escape in mice

A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection

An Evolutionary Insertion in the Mxra8 Receptor-Binding Site Confers Resistance to Alphavirus Infection and Pathogenesis

Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement

Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress

Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis

Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes

Drug analog inhibition of indoleamine 2,3-dioxygenase (IDO) activity modifies pattern recognition receptor expression and proinflammatory cytokine responses early during influenza virus infection.

Human monoclonal antibodies against Ross River virus target epitopes within the E2 protein and protect against disease

Immune-Mediated Protection and Pathogenesis of Chikungunya Virus

Indoleamine 2,3-dioxygenase (IDO) activity during the primary immune response to influenza infection modifies the memory T cell response to influenza challenge

Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection

Interferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells After Influenza Virus Infection

Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus

Isospora troglodytes n. sp. (Apicomplexa: Eimeriidae), a new coccidian species from wrens of Costa Rica.

MUTATIONS IN THE E2 GLYCOPROTEIN AND THE 3' UNTRANSLATED REGION ENHANCE CHIKUNGUNYA VIRUS VIRULENCE IN MICE.

Modified mRNA Vaccines Protect against Zika Virus Infection

Modified mRNA Vaccines Protect against Zika Virus Infection

Mxra8 is a receptor for multiple arthritogenic alphaviruses

Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis

Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice

Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes

Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence

Potently neutralizing and protective human antibodies against SARS-CoV-2

Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals

Publisher Correction: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function

SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function

Structural basis of Chikungunya virus inhibition by monoclonal antibodies

Subsisting H1N1 influenza memory responses are insufficient to protect from pandemic H1N1 influenza challenge in C57BL/6 mice

Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques